Fewer Allergan sales reps, still serving ODs

Article

Recently, Allergan reduced its sales force, causing concern in the marketplace about sales rep availability to optometry. Some practitioners believed the move was a perceived slight to optometry in favor of ophthalmology, adding to a long-held perception that Allergan is not committed to optometry.

Recently, Allergan reduced its sales force, causing concern in the marketplace about sales rep availability to optometry. Some practitioners believed the move was a perceived slight to optometry in favor of ophthalmology, adding to a long-held perception that Allergan is not committed to optometry.

Related: Allergan SECO boot camp 

“We are absolutely dedicated to optometry,” says David Gibson, director, optometric professional relations and strategic initiatives, speaking exclusively to Optometry Times. “It’s one of our big growth areas at Allergan. We have to make sure that we’re totally working to ensure coverage of optometrists.”

The sales team is currently being realigned to maximize sales efforts, according to the company.

“Back during our second quarter earnings call, CEO David Pyott indicated there would be significant changes to our structure,” says Gibson. “Our goal is to be a leaner and more efficient company. As part of that, our eyecare sales team is being realigned. We traditionally had four parallel selling teams calling on ODs and MDs. One of those four has been a contract sales force. With changes being made, we decided to eliminate our contract sales force and realign the rest of the group to maximize our efforts.”

According to Gibson, these changes mean an increase in the number of sales reps to optometry as well as four new positions in the optometry marketing team.

“We’ve been working hard over the past several years to increase the number of programs dedicated to optometry,” he says. “None of those are going away. We wanted to protect these efforts and position ourselves for growth in optometry and continue to deliver on these resources.”

Those optometry programs include:

• Academic Partnership Program to provide education, support and resources to U.S. optometry schools

• Optometry Jumpstart to support new optometrists within the first five years of graduation

• Pathways in Medical optometry Boot Camps to train optometrists on medical optometry

• Visionary Insight for Eye Care Women (VIEW) programs to provide training and inspiration to current and future female optometric leaders 

Recent Videos
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.